Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…
Pharmaceuticals, Biotechnology and Life Sciences
FOSTER CITY, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…
PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage…
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company using its proprietary Cloudbreak® platform…
SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…
NEWARK, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies…
PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion…
PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the completion…
KUALA LUMPUR, Malaysia, Sept. 05, 2023 (GLOBE NEWSWIRE) — The Global HPV Consortium, a worldwide public and private collaboration focused…
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private…
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position…